Evidence map›Paper›PMID 41308032›Full record

ArticleBioscience reports2025

Retraction: STEAP1 facilitates metastasis and epithelial-mesenchymal transition of lung adenocarcinoma via the JAK2/STAT3 signaling pathway.

Shu-Fen Huo, Wen-Li Sheng, Min Yu, Xiao-Ping Ren, Hong-Xia Wen, Chun-Yan Chai, Li Sun, Ke Hui, Ling-Hua Liu, Sheng-Hong Wei and 3 more

Abstract readRetraction Notice
In one paragraph

Article in Bioscience reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Shu-Fen HuoSecond Department of Respiratory Medicine, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Wen-Li ShengSecond Department of Respiratory Medicine, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Min YuDepartment of Medical Oncology, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Xiao-Ping RenSecond Department of Respiratory Medicine, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Hong-Xia WenSecond Department of Respiratory Medicine, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Chun-Yan ChaiThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Li SunThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Ke HuiThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Ling-Hua LiuThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Sheng-Hong WeiThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Xiao-Xiao WangThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Yi WangThe First Ward, Shannxi Provincial People's Hospital, Xi'an, 710068, China.
Ying-Xuan TianSecond Department of Respiratory Medicine, Shannxi Provincial People's Hospital, Xi'an, 710068, China.ORCID 0000-0003-0042-5271

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41308032
PMCPMC12751035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.